Changing the Status Quo of Vaccine Production
Precision NanoSystems maintains that mRNA and LNP technologies, microfluidics, and distributed manufacturing will revamp vaccine production.
Health Aff Panel For Pandemic Preparedness Epic Public Health Crisis Vaccine Development Readiness Response Program World Economic Forum
Source: genengnews.com